Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1)

Oncotarget

Volumn 7, Issue 1, 2016, Pages 241-254

  Lu, Zhanping ^a   Xiao, Zelin ^a   Liu, Fabao ^a   Cui, Ming ^a   Li, Weiping ^a,b   Yang, Zhe ^a   Li, Jiong ^a   Ye, Lihong ^a   Zhang, Xiaodong ^a  

^a NANKAI UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; E2F1; HCC; HULC; MiR 107; SPHK1

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA 107; SPHINGOSINE KINASE 1; TRANSCRIPTION FACTOR E2F1; 3' UNTRANSLATED REGION; E2F1 PROTEIN, HUMAN; HULC LONG NON-CODING RNA, HUMAN; MICRORNA; MIRN107 MICRORNA, HUMAN; PHOSPHOTRANSFERASE; SPHINGOSINE KINASE;

3' UNTRANSLATED REGION; ANIMAL TISSUE; ARTICLE; BASE PAIRING; CANCER TISSUE; CHICKEN; CHORIOALLANTOIC MEMBRANE ASSAY; CHROMATIN IMMUNOPRECIPITATION; CORRELATION ANALYSIS; ELECTROPHORETIC MOBILITY; EMBRYO; GENE; GENE FUNCTION; HEPATOMA CELL; HULC GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION; ADULT; AGED; ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; CHICK EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VASCULARIZATION; WESTERN BLOTTING; XENOGRAFT;

3' UNTRANSLATED REGIONS; ADULT; AGED; ANIMALS; BLOTTING, WESTERN; CHICK EMBRYO; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, LONG NONCODING; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84997319192     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/ONCOTARGET.6280     Document Type: Article

References (45)

1. Ponting CP, Oliver PL and Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136:629-641
2. Mazar J, Zhao W, Khalil AM, Lee B, Shelley J, Govindarajan SS, Yamamoto F, Ratnam M, Aftab MN, Collins S, Finck BN, Han X, Mattick JS, Dinger ME and Perera RJ. The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget. 2014; 5:8959-8969. Doi: 10.18632/oncotarget.1863
3. Li H, Yu B, Li J, Su L, Yan M, Zhu Z and Liu B. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014; 5:2318-2329 Doi: 10.18632/oncotarget.1913
4. Xue Y, Ma G, Zhang Z, Hua Q, Chu H, Tong N, Yuan L, Qin C, Yin C, Zhang Z and Wang M. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget. 2015; 6:484-493. Doi: 10.18632/oncotarget.2861
5. Quagliata L, Matter MS, Piscuoglio S, Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z, Boldanova T, Andersen JB, Hammerle M, Tornillo L, Heim MH, Diederichs S, Cillo C, et al. Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2014; 59:911-923
6. Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, Buck CR, Denk H, Schroeder R, Trauner M and Zatloukal K. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007; 132:330-342
7. Hammerle M, Gutschner T, Uckelmann H, Ozgur S, Fiskin E, Gross M, Skawran B, Geffers R, Longerich T, Breuhahn K, Schirmacher P, Stoecklin G and Diederichs S. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology. 2013; 58:1703-1712
8. Matouk IJ, Abbasi I, Hochberg A, Galun E, Dweik H and Akkawi M. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. European journal of gastroenterology & hepatology. 2009; 21:688-692
9. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F and Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic acids research. 2010; 38:5366-5383
10. Du Y, Kong G, You X, Zhang S, Zhang T, Gao Y, Ye L and Zhang X. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. The Journal of biological chemistry. 2012; 287:26302-26311
11. Shukla R, Upton KR, Munoz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T, Brennan PM, Baillie JK, Collino A, Ghisletti S, Sinha S, Iannelli F, Radaelli E, Dos Santos A, Rapoud D, Guettier C, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell. 2013; 153:101-111
12. Gore J, Craven KE, Wilson JL, Cote GA, Cheng M, Nguyen HV, Cramer HM, Sherman S and Korc M. TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesis. Oncotarget. 2015; 6:7504-7521 Doi: 10.18632/oncotarget.3233
13. Chuang JY, Chen PC, Tsao CW, Chang AC, Lein MY, Lin CC, Wang SW, Lin CW and Tang CH. WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression. Oncotarget. 2015; 6:4239-4252. Doi: 10.18632/oncotarget.2978
14. Giacomini A, Matarazzo S, Pagano K, Ragona L, Rezzola S, Corsini M, Di Salle E, Presta M and Ronca R. A long pentraxin-3-derived pentapeptide for the therapy of FGF8bdriven steroid hormone-regulated cancers. Oncotarget. 2015; 6:13790-802. Doi:10.18632/oncotarget.3831
15. Gordon MS, Mendelson DS and Kato G. Tumor angiogenesis and novel antiangiogenic strategies. International journal of cancer Journal international du cancer. 2010; 126:1777-1787
16. Xue G, Yan HL, Zhang Y, Hao LQ, Zhu XT, Mei Q and Sun SH. c-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2alpha and promotes tumor angiogenesis and metastasis by upregulating FGF2. Oncogene. 2015;34:1393-406
17. Alvarez SE, Harikumar KB, Hait NC, Allegood J, Strub GM, Kim EY, Maceyka M, Jiang H, Luo C, Kordula T, Milstien S and Spiegel S. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature. 2010; 465:1084-1088
18. Liu Y, Deng J, Wang L, Lee H, Armstrong B, Scuto A, Kowolik C, Weiss LM, Forman S and Yu H. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood. 2012; 120:1458-1465
19. Nagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, Milstien S, Zhou H, Spiegel S and Takabe K. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. Cancer research. 2012; 72:726-735
20. Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marfe G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, et al. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models. Clinical cancer research. 2013; 19:138-147
21. Yang L, Yue S, Yang L, Liu X, Han Z, Zhang Y and Li L. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. Journal of hepatology. 2013; 59:114-123
22. Weis SM and Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nature medicine. 2011; 17:1359-1370
23. Maceyka M, Harikumar KB, Milstien S and Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends in cell biology. 2012; 22:50-60
24. Bao M, Chen Z, Xu Y, Zhao Y, Zha R, Huang S, Liu L, Chen T, Li J, Tu H and He X. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver international. 2012; 32:331-338
25. Merdzhanova G, Gout S, Keramidas M, Edmond V, Coll JL, Brambilla C, Brambilla E, Gazzeri S and Eymin B. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo. Oncogene. 2010; 29:5392-5403
26. Engelmann D, Mayoli-Nussle D, Mayrhofer C, Furst K, Alla V, Stoll A, Spitschak A, Abshagen K, Vollmar B, Ran S and Putzer BM. E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B. Journal of molecular cell biology. 2013; 5:391-403
27. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH and Wang DZ. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of clinical investigation. 2009; 119:2772-2786
28. Qiu MT, Hu JW, Yin R and Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013; 34:613-620
29. Huang JL, Zheng L, Hu YW and Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis. 2014; 35:507-514
30. Pyne NJ and Pyne S. Sphingosine 1-phosphate and cancer. Nature reviews Cancer. 2010; 10:489-503
31. Gordon FE, Nutt CL, Cheunsuchon P, Nakayama Y, Provencher KA, Rice KA, Zhou Y, Zhang X and Klibanski A. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology. 2010; 151:2443-2452
32. Michalik KM, You X, Manavski Y, Doddaballapur A, Zornig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, Boon RA and Dimmeler S. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circulation research. 2014; 114:1389-1397
33. Yuan SX, Yang F, Yang Y, Tao QF, Zhang J, Huang G, Yang Y, Wang RY, Yang S, Huo XS, Zhang L, Wang F, Sun SH and Zhou WP. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology. 2012; 56:2231-2241
34. He J, Zhang W, Zhou Q, Zhao T, Song Y, Chai L and Li Y. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. The international journal of biochemistry & cell biology. 2013; 45:1962-1973
35. Li XY, Luo QF, Wei CK, Li DF, Li J and Fang L. MiRNA-107 inhibits proliferation and migration by targeting CDK8 in breast cancer. International journal of clinical and experimental medicine. 2014; 7:32-40
36. Huang Y, Tai AW, Tong S and Lok AS. HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. Journal of hepatology. 2013; 58:1068-1073
37. Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC, Wang SB, Wang YZ, Yang Y, Yang N, Zhou WP, Yang GS, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer cell. 2014; 25:666-681
38. Kang Y, Wang F, Feng J, Yang D, Yang X and Yan X. Knockdown of CD146 reduces the migration and proliferation of human endothelial cells. Cell research. 2006; 16:313-318
39. Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L and Zhang X. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Carcinogenesis. 2011; 32:1190-1197
40. Schmittgen TD and Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3:1101-1108
41. Xu F, You X, Liu F, Shen X, Yao Y, Ye L and Zhang X. The oncoprotein HBXIP up-regulates Skp2 via activating transcription factor E2F1 to promote proliferation of breast cancer cells. Cancer letters. 2013; 333:124-132
42. Liu Y, Saiyan S, Men TY, Gao HY, Wen C, Zhou X, Wu CT, Wang LS and Cui CP. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors. J Pathol. 2013; 230:365-376
43. Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, Wu J, Hu B, Cheng SY, Li M and Li J. TGF-beta induces miR-182 to sustain NF-kappaB activation in glioma subsets. The Journal of clinical investigation. 2012; 122:3563-3578
44. Hilkens P, Fanton Y, Martens W, Gervois P, Struys T, Politis C, Lambrichts I and Bronckaers A. Pro-angiogenic impact of dental stem cells in vitro and in vivo. Stem Cell Res. 2014; 12:778-790
45. Zhang T, Zhang J, You X, Liu Q, Du Y, Gao Y, Shan C, Kong G, Wang Y, Yang X, Ye L and Zhang X. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology. 2012; 56:2051-2059